Telix Pharmaceuticals | TLX - Lucro Operacional

Preço das Ações
10.51
Mudança Diária
0.42 4.16%
Mensal
6.59%
Anual
-62.00%
Q1 Previsão
9.56




Lucro Operacional Alterar Data
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Mayne Pharma AUD -3.3M 15.67M 2024-06
Medical Developments International AUD -36K 444K 2025-12
Mesoblast USD -42.11M 21.69M 2025-06
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Pacific Edge NZD -19.4M 2.91M 2025-12
Paradigm Biopharmaceuticals AUD -8.5M 2.57M 2025-06
Polynovo AUD 513K 902K 2024-06
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 500.3M 37.95M 2025-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12